Skip to main content
Top
Published in: Annals of Surgical Oncology 4/2012

01-04-2012 | Endocrine Tumors

Is Focused Minimally Invasive Parathyroidectomy Appropriate for Patients With Familial Primary Hyperparathyroidism?

Authors: Ruth S. Prichard, FRCSI, Christine J. O’Neill, FRACS, Jennifer J. Oucharek, FRCSC, Rebecca S. Sippel, MD, FACS, Leigh W. Delbridge, MD, FRACS, Stanley B. Sidhu, PhD, FRACS, Herbert Chen, MD, FACS

Published in: Annals of Surgical Oncology | Issue 4/2012

Login to get access

Abstract

Background

The aim of this study was to determine whether a focused minimally invasive parathyroidectomy (MIP) for patients with primary hyperparathyroidism and concordant pre-operative localization studies is appropriate for patients with a family history of the disease. Familial hyperparathyroidism may be seen as a chronic disease in which recurrence is inevitable. Patients frequently undergo subtotal or total parathyroidectomy for perceived 4-gland parathyroid hyperplasia in an attempt to reduce this risk. Controversy remains regarding whether a MIP is appropriate in this setting.

Methods

Patients undergoing an MIP were identified from prospectively maintained databases. Chart review confirmed the presence of a family history of hyperparathyroidism in a direct relative. Patients with and without a family history were compared regarding overall complications, recurrence, and cure rates.

Results

A total of 1,652 patients underwent a MIP. Of these, 34 patients had a positive family history. There was no statistically significant difference in age, gender, preoperative biochemistry, gland weight, or complication rates between the groups. The cure rate at 6 months from a single operation was equivalent between the 2 groups (97 vs. 98%). With a median of 39 months follow-up, the recurrence rate was higher in those with a family history compared with those without (8.8 vs 1.1%; P = 0.002). Reoperation was successful in the small population of familial patients who did present with recurrent hyperparathyroidism.

Conclusions

The vast majority of patients who underwent a MIP were surgically cured. Although recurrence rates remain higher in the familial hyperparathyroidism group, these data suggest that this alone should not be a contraindication to MIP.
Literature
1.
go back to reference Kebebew E, Clark OH. Parathyroid adenoma, hyperplasia and carcinoma: localization, technical details of primary neck exploration and treatment of hypercalcaemic crisis. Surg Oncol Clin N Am. 1998;7:721–48.PubMed Kebebew E, Clark OH. Parathyroid adenoma, hyperplasia and carcinoma: localization, technical details of primary neck exploration and treatment of hypercalcaemic crisis. Surg Oncol Clin N Am. 1998;7:721–48.PubMed
2.
go back to reference Lew JI, Soloranzo CC. Surgical management of primary hyperparathyroidism: State of the art. Surg Clin N Am. 2009;89:1205–25.PubMedCrossRef Lew JI, Soloranzo CC. Surgical management of primary hyperparathyroidism: State of the art. Surg Clin N Am. 2009;89:1205–25.PubMedCrossRef
3.
go back to reference Mack LA, Pasieka JL. Asymptomatic primary hyperparathyroidism: a surgical perspective. Surg Clin N Am. 2004;84:803–16.PubMedCrossRef Mack LA, Pasieka JL. Asymptomatic primary hyperparathyroidism: a surgical perspective. Surg Clin N Am. 2004;84:803–16.PubMedCrossRef
4.
go back to reference Chen H, Mack E, Starling JR. A comprehensive evaluation of peri-operative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg. 2005;242:375–83.PubMed Chen H, Mack E, Starling JR. A comprehensive evaluation of peri-operative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg. 2005;242:375–83.PubMed
5.
go back to reference Palazzo FF, Delbridge LW. Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg Clin N Am. 2004;84:717–34.PubMedCrossRef Palazzo FF, Delbridge LW. Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg Clin N Am. 2004;84:717–34.PubMedCrossRef
6.
go back to reference Irvin GL III, Soloranzo CC, Carneiro DM. Quick intra-operative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rates and predict outcome. World J Surg. 2004;28:1287–92.PubMedCrossRef Irvin GL III, Soloranzo CC, Carneiro DM. Quick intra-operative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rates and predict outcome. World J Surg. 2004;28:1287–92.PubMedCrossRef
7.
go back to reference Siperstein A, Berber E, Mackey R. Prospective evaluation of sestamibi scan, ultrasonography and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery. 2004;136:872–80.PubMedCrossRef Siperstein A, Berber E, Mackey R. Prospective evaluation of sestamibi scan, ultrasonography and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery. 2004;136:872–80.PubMedCrossRef
8.
go back to reference Chen H, Pruhs ZM, Starling JR. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138:583–90.PubMedCrossRef Chen H, Pruhs ZM, Starling JR. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138:583–90.PubMedCrossRef
9.
go back to reference Grant CS, Thompson G, Farley D. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo clinic experience. Arch Surg. 2005;140:472–8.PubMedCrossRef Grant CS, Thompson G, Farley D. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo clinic experience. Arch Surg. 2005;140:472–8.PubMedCrossRef
10.
go back to reference Lal A, Bianco J, Chen H. Radioguided parathyroidectomy in patients with familial hyperparathyroidism. Ann Surg Oncol. 2007;14:739–43.PubMedCrossRef Lal A, Bianco J, Chen H. Radioguided parathyroidectomy in patients with familial hyperparathyroidism. Ann Surg Oncol. 2007;14:739–43.PubMedCrossRef
11.
go back to reference Stalberg P, Carling T. Familial parathyroid tumours: diagnosis and management. World J Surg. 2009;33:2234–43.PubMedCrossRef Stalberg P, Carling T. Familial parathyroid tumours: diagnosis and management. World J Surg. 2009;33:2234–43.PubMedCrossRef
12.
go back to reference Goldman L, Smyth FS. Hyperparathyroidism in sibling. Am Surg. 1936;104:971–81. Goldman L, Smyth FS. Hyperparathyroidism in sibling. Am Surg. 1936;104:971–81.
13.
go back to reference Warner JV, Nyholt DR, Busfield F. Familial isolated hyperparathyroidism is linked to a 1.7 Mb regions on chromosome 2p3.314. J Med Genet. 2006;43:e12.PubMedCrossRef Warner JV, Nyholt DR, Busfield F. Familial isolated hyperparathyroidism is linked to a 1.7 Mb regions on chromosome 2p3.314. J Med Genet. 2006;43:e12.PubMedCrossRef
14.
go back to reference Carling T, Udelsman R. Parathyroid surgery in familial hyperparathyroid disorders. J Inter Med. 2005;257:27–37.CrossRef Carling T, Udelsman R. Parathyroid surgery in familial hyperparathyroid disorders. J Inter Med. 2005;257:27–37.CrossRef
15.
go back to reference Hellman P, Skogseid B, Oberg K. Primary and re-operative parathyroid operations in hyperparathyroidism of multiple endocrine type 1. Surgery. 1988;124:993–9.CrossRef Hellman P, Skogseid B, Oberg K. Primary and re-operative parathyroid operations in hyperparathyroidism of multiple endocrine type 1. Surgery. 1988;124:993–9.CrossRef
16.
go back to reference Burgess JR, David R, Parameswaran V. The outcome of subtotal thyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 1998;133:126–9.PubMedCrossRef Burgess JR, David R, Parameswaran V. The outcome of subtotal thyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 1998;133:126–9.PubMedCrossRef
17.
go back to reference Thompson NW. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med. 1995;238:269–80.PubMedCrossRef Thompson NW. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med. 1995;238:269–80.PubMedCrossRef
18.
go back to reference Goudet P, Cougard P, Verges B. Hyperparathyroidism in multiple endocrine neoplasia type 1: surgical trends and results of a 256-patient series from Groupe D’Etude des Neoplasies Endocriniennes Multiples Study Group. World J Surg. 2001;25:886–90.PubMedCrossRef Goudet P, Cougard P, Verges B. Hyperparathyroidism in multiple endocrine neoplasia type 1: surgical trends and results of a 256-patient series from Groupe D’Etude des Neoplasies Endocriniennes Multiples Study Group. World J Surg. 2001;25:886–90.PubMedCrossRef
19.
go back to reference O’Riordain DS, O’Brien T, Grant CS. Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery. 1993;114:1031–7.PubMed O’Riordain DS, O’Brien T, Grant CS. Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery. 1993;114:1031–7.PubMed
20.
go back to reference Elaraj DM, Skarulis MC, Libutti SK. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003;134:858–64.PubMedCrossRef Elaraj DM, Skarulis MC, Libutti SK. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003;134:858–64.PubMedCrossRef
21.
go back to reference Hubbard JG, Sebag F, Maweja S. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 2006;141:235–9.PubMedCrossRef Hubbard JG, Sebag F, Maweja S. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 2006;141:235–9.PubMedCrossRef
22.
go back to reference Tonelli F, Spini S, Tommasi M. Intra-operative parathyroid hormone measurement in patients with multiple endocrine neoplasia type 1 syndrome and hyperparathyroidism. World J Surg. 2000;24:556–62.PubMedCrossRef Tonelli F, Spini S, Tommasi M. Intra-operative parathyroid hormone measurement in patients with multiple endocrine neoplasia type 1 syndrome and hyperparathyroidism. World J Surg. 2000;24:556–62.PubMedCrossRef
23.
go back to reference Dotzenrath C, Cupisti K, Goretzki PE. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia type I and IIa: is a more or less extended operation essential. Eur J Surg. 2001;167:173–8.PubMedCrossRef Dotzenrath C, Cupisti K, Goretzki PE. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia type I and IIa: is a more or less extended operation essential. Eur J Surg. 2001;167:173–8.PubMedCrossRef
24.
go back to reference Kivlen MH, Bartlett DL, Libutti SK. Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2001;130:991–8.PubMedCrossRef Kivlen MH, Bartlett DL, Libutti SK. Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2001;130:991–8.PubMedCrossRef
25.
go back to reference Sharma J, Weber CJ. Surgical therapy for familial hyperparathyroidism. Am Surg. 2009;75:579–83.PubMed Sharma J, Weber CJ. Surgical therapy for familial hyperparathyroidism. Am Surg. 2009;75:579–83.PubMed
26.
go back to reference Huang SM, Duh QY, Shaver J. Familial hyperparathyroidism without multiple endocrine neoplasia. World J Surg. 1997;21:22–9.PubMedCrossRef Huang SM, Duh QY, Shaver J. Familial hyperparathyroidism without multiple endocrine neoplasia. World J Surg. 1997;21:22–9.PubMedCrossRef
27.
go back to reference Barry MK, van Heerden JA, Grant CS. Is familial hyperparathyroidism a unique disease? Surgery. 1997;122:1028–33.PubMedCrossRef Barry MK, van Heerden JA, Grant CS. Is familial hyperparathyroidism a unique disease? Surgery. 1997;122:1028–33.PubMedCrossRef
Metadata
Title
Is Focused Minimally Invasive Parathyroidectomy Appropriate for Patients With Familial Primary Hyperparathyroidism?
Authors
Ruth S. Prichard, FRCSI
Christine J. O’Neill, FRACS
Jennifer J. Oucharek, FRCSC
Rebecca S. Sippel, MD, FACS
Leigh W. Delbridge, MD, FRACS
Stanley B. Sidhu, PhD, FRACS
Herbert Chen, MD, FACS
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 4/2012
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-2092-6

Other articles of this Issue 4/2012

Annals of Surgical Oncology 4/2012 Go to the issue